93 related articles for article (PubMed ID: 34403806)
1. CRISPR/Cas9-mediated gene editing on Sox2ot promoter leads to its truncated expression and does not influence neural tube closure and embryonic development in mice.
Li PY; Li SQ; Gao SG; Dong DY
Biochem Biophys Res Commun; 2021 Oct; 573():107-111. PubMed ID: 34403806
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of mouse and human preimplantation development following POU5F1 CRISPR/Cas9 targeting reveals interspecies differences.
Stamatiadis P; Boel A; Cosemans G; Popovic M; Bekaert B; Guggilla R; Tang M; De Sutter P; Van Nieuwerburgh F; Menten B; Stoop D; Chuva de Sousa Lopes SM; Coucke P; Heindryckx B
Hum Reprod; 2021 Apr; 36(5):1242-1252. PubMed ID: 33609360
[TBL] [Abstract][Full Text] [Related]
3. CRISPR-Cas9 editing of non-coding genomic loci as a means of controlling gene expression in the sea urchin.
Pieplow A; Dastaw M; Sakuma T; Sakamoto N; Yamamoto T; Yajima M; Oulhen N; Wessel GM
Dev Biol; 2021 Apr; 472():85-97. PubMed ID: 33482173
[TBL] [Abstract][Full Text] [Related]
4. Allele-specific repression of Sox2 through the long non-coding RNA Sox2ot.
Messemaker TC; van Leeuwen SM; van den Berg PR; 't Jong AEJ; Palstra RJ; Hoeben RC; Semrau S; Mikkers HMM
Sci Rep; 2018 Jan; 8(1):386. PubMed ID: 29321583
[TBL] [Abstract][Full Text] [Related]
5. In Vivo CRISPR/Cas9-Based Targeted Disruption and Knockin of a Long Noncoding RNA.
Cheng X; Peters ST; Pruett-Miller SM; Saunders TL; Joe B
Methods Mol Biol; 2021; 2254():305-321. PubMed ID: 33326084
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA SOX2OT: expression signature, splicing patterns, and emerging roles in pluripotency and tumorigenesis.
Shahryari A; Jazi MS; Samaei NM; Mowla SJ
Front Genet; 2015; 6():196. PubMed ID: 26136768
[TBL] [Abstract][Full Text] [Related]
7. Identification of new SOX2OT transcript variants highly expressed in human cancer cell lines and down regulated in stem cell differentiation.
Saghaeian Jazi M; Samaei NM; Ghanei M; Shadmehr MB; Mowla SJ
Mol Biol Rep; 2016 Feb; 43(2):65-72. PubMed ID: 26703382
[TBL] [Abstract][Full Text] [Related]
8. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA Sox2ot and transcription factor YY1 co-regulate the differentiation of cortical neural progenitors by repressing Sox2.
Knauss JL; Miao N; Kim SN; Nie Y; Shi Y; Wu T; Pinto HB; Donohoe ME; Sun T
Cell Death Dis; 2018 Jul; 9(8):799. PubMed ID: 30038234
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of long non-coding RNA SOX2OT downregulates SOX2 to improve hippocampal neurogenesis and cognitive function in a mouse model of sepsis-associated encephalopathy.
Yin J; Shen Y; Si Y; Zhang Y; Du J; Hu X; Cai M; Bao H; Xing Y
J Neuroinflammation; 2020 Oct; 17(1):320. PubMed ID: 33100215
[TBL] [Abstract][Full Text] [Related]
11. Two novel splice variants of SOX2OT, SOX2OT-S1, and SOX2OT-S2 are coupregulated with SOX2 and OCT4 in esophageal squamous cell carcinoma.
Shahryari A; Rafiee MR; Fouani Y; Oliae NA; Samaei NM; Shafiee M; Semnani S; Vasei M; Mowla SJ
Stem Cells; 2014 Jan; 32(1):126-34. PubMed ID: 24105929
[TBL] [Abstract][Full Text] [Related]
12. Genetic Editing of Long Noncoding RNA Using CRISPR/Cas9 Technology.
Larter K; Yi B; Xi Y
Methods Mol Biol; 2021; 2372():169-177. PubMed ID: 34417751
[TBL] [Abstract][Full Text] [Related]
13. CRISPR/Cas9-mediated genome editing in sea urchins.
Lin CY; Oulhen N; Wessel G; Su YH
Methods Cell Biol; 2019; 151():305-321. PubMed ID: 30948015
[TBL] [Abstract][Full Text] [Related]
14. CRISPR/Cas9-mediated deletion of lncRNA Gm26878 in the distant Foxf1 enhancer region.
Szafranski P; Karolak JA; Lanza D; Gajęcka M; Heaney J; Stankiewicz P
Mamm Genome; 2017 Aug; 28(7-8):275-282. PubMed ID: 28405742
[TBL] [Abstract][Full Text] [Related]
15. CRISPR/Cas9-mediated genome editing of Schistosoma mansoni acetylcholinesterase.
You H; Mayer JU; Johnston RL; Sivakumaran H; Ranasinghe S; Rivera V; Kondrashova O; Koufariotis LT; Du X; Driguez P; French JD; Waddell N; Duke MG; Ittiprasert W; Mann VH; Brindley PJ; Jones MK; McManus DP
FASEB J; 2021 Jan; 35(1):e21205. PubMed ID: 33337558
[TBL] [Abstract][Full Text] [Related]
16. Emerging role of long non-coding RNA SOX2OT in SOX2 regulation in breast cancer.
Askarian-Amiri ME; Seyfoddin V; Smart CE; Wang J; Kim JE; Hansji H; Baguley BC; Finlay GJ; Leung EY
PLoS One; 2014; 9(7):e102140. PubMed ID: 25006803
[TBL] [Abstract][Full Text] [Related]
17. Application of CRISPR-Cas9 for Long Noncoding RNA Genes in Cancer Research.
Zhen S; Li X
Hum Gene Ther; 2019 Jan; 30(1):3-9. PubMed ID: 30045635
[TBL] [Abstract][Full Text] [Related]
18. CRISPR/Cas9-Enabled Multiplex Genome Editing and Its Application.
Minkenberg B; Wheatley M; Yang Y
Prog Mol Biol Transl Sci; 2017; 149():111-132. PubMed ID: 28712493
[TBL] [Abstract][Full Text] [Related]
19. Yin Yang-1 suppresses pancreatic ductal adenocarcinoma cell proliferation and tumor growth by regulating SOX2OT-SOX2 axis.
Zhang JJ; Zhu Y; Zhang XF; Liu DF; Wang Y; Yang C; Shi GD; Peng YP; Zhang K; Tian L; Miao Y; Jiang KR
Cancer Lett; 2017 Nov; 408():144-154. PubMed ID: 28867247
[TBL] [Abstract][Full Text] [Related]
20. CRISPR/Cas9-mediated genome editing of Epstein-Barr virus in human cells.
Yuen KS; Chan CP; Wong NM; Ho CH; Ho TH; Lei T; Deng W; Tsao SW; Chen H; Kok KH; Jin DY
J Gen Virol; 2015 Mar; 96(Pt 3):626-636. PubMed ID: 25502645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
